Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Lampe, C.; Pick, M.; Knuf, M.

Pharmakologische Neuroprotektion bei Frühgeborenen

Kinderärztliche Praxis. Bd. 85. 2015 S. 23-26


Niesvizky, Ruben; Badros, Ashraf Z.; Costa, Luciano J. et al.

Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma

LEUKEMIA & LYMPHOMA. Bd. 56. H. 12. 2015 S. 3320-3328


Zuraw, B. L.; Cicardi, M.; Longhurst, H. J. et al.

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate

ALLERGY. Bd. 70. H. 10. 2015 S. 1319-1328


Wolin, Edward M.; Jarzab, Barbara; Eriksson, Barbro et al.

Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues

DRUG DESIGN DEVELOPMENT AND THERAPY. Bd. 9. 2015 S. 5075-5086




Krebs, F.; Uenal, Oe; Hahn, S. A. et al.

Phenotypical changes of melanoma cells and T cell subsets providing a loophole for relapse in Vemurafenib therapy

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 13. 2015 S. 32-32


Michal, M.; Schulz, A.; Coldewey, M. et al.

PHQ-2 and GAD-2 scores predict mortality in patients undergoing oral anticoagulation

JOURNAL OF PSYCHOSOMATIC RESEARCH. Bd. 78. H. 6. 2015 S. 615-615


Spindeldreier, Kirsten C.; Thiesen, Judith; Kraemer, Irene

Physicochemical stability of cabazitaxel containing premix solution and diluted infusion solutions

EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE. Bd. 22. H. 5. 2015 S. 260-266


Spindeldreier, K; Thiesen, j

Physicochemical stability of cabazitaxel containing premix solution and diluted infusion solutions 2015

European Journal of hospital pharmacy. Bd. 22. 2015 S. 260-266